Results 91 to 100 of about 8,882 (195)

The GLP‐1 Receptor Agonist Paradox in Dermatology: Why We Cannot Afford the Knowledge Gap

International Journal of Dermatology, Volume 65, Issue 7, Page 1361-1362, July 2026.
Ramy Awadalla, Derek Davies
wiley   +1 more source

RASGRP1 Deficiency Manifesting as Severe Vasculopathy and Fatal Autoimmune Hemolytic Anemia

eJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT Background RASGRP1 deficiency is a rare inborn error of immunity characterized by immunodeficiency, autoimmunity, and lymphoproliferation. Results We report a 5‐year‐old male with novel homozygous splice‐donor mutations in RASGRP1(c.1720+1G>A and c.1720+2T>C) who presented with severe vasculopathy (ischemic stroke and thrombosis), secondary ...
Kosar Asna Ashari, Bahareh Yaghmaie, Neda Pak, Mohammad Shahrooei, Vahid Ziaee, Nima Parvaneh   +5 more
wiley   +1 more source

Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor in primary care: Case report

Turkish Journal of Family Practice
Bullous pemphigoid is the most common bullous chronic autoimmune skin disease. Recent studies suggest dipeptidyl peptidase-4 inhibitors used in the treatment of type-2 diabetes as possible predisposing agents of bullous pemphigoid.
Kübra Kurt
doaj   +1 more source

Risk of persistent hypogammaglobulinaemia in children with autoimmune bullous dermatoses treated with rituximab

Journal of the European Academy of Dermatology and Venereology, EarlyView.
S. Benkimoun, A. Welfringer‐Morin, V. Barlogis, R. Gravier Dumonceau, E. Bourrat, C. Chiaverini, C. Léauté‐Labrèze, P. Joly, B. Tedbirt, A.‐C. Bursztejn, G. Font, C. Bodemer, M.‐A. Richard, S. Mallet, Groupe Bulles of the French Society of Dermatology; Clinical Research Group of the French Society of Pediatric Dermatology   +14 more
wiley   +1 more source

Detection of Diagnostic Antibodies in Immune‐Mediated Diseases: A Focus on Antigens and Technologies

ChemBioChem, Volume 27, Issue 9, 14 May 2026.
This review explores autoantibody detection in immune‐mediated diseases, highlighting autoantigens including post‐translational modifications. We compared enzyme‐linked immunosorbent assay and indirect immunofluorescence with automated chemiluminescence platforms.
Silvia Bracci, Feliciana Real‐Fernandez, Federico Pratesi, Francesca Nuti, Paolo Rovero, Anna Maria Papini   +5 more
wiley   +1 more source

The association between COVID‐19 vaccines and bullous pemphigoid risk: A UK population‐based study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Mikolaj Swiderski, Yana Vinogradova, Matthew J. Ridd, Zenas Z. N. Yiu, Antonia Lloyd‐Lavery, Vibhore Prasad, Bruno Gran, Sonia Gran   +7 more
wiley   +1 more source

Exploring Pruritus in Bullous Pemphigoid: Analysis of QOL Metrics and Potential Biological Mechanisms

JID Innovations
Bullous pemphigoid is a devastating autoimmune blistering disease with need for improved therapeutics. Limited data are available on the overall burden of pruritus and alterations over time; however, treatment of itch-specific pathways may provide novel ...
Olive C. Osuoji, Taryn DeGrazia, Robin Rolader, Emily F. Cole, Katy Lawson, Henry Hilley, Yanyan Xing, Liang Han, Sarah Chisolm, Henry Claussen, Xiaobo Yan, Yuxian Sun, Yuan Liu, Suephy C. Chen, Ron J. Feldman   +14 more
doaj   +1 more source

Clinicoepidemiological Features of 82 Cases of Bullous Pemphigoid in Tehran, Iran

Acta Medica Iranica, 2018
Bullous Pemphigoid is a chronic immunobullous disease, characterized by subepidermal bulla on the skin and mucosa. The purpose of the present study was to investigate the clinicoepidemiological features of bullous pemphigoid in Iranian patients.
Kamran Balighi, Maryam Daneshpazhooh, Hamidreza Mahmoudi, Maryam Nasimi, Alireza Delavari, Arghavan Azizpour   +5 more
doaj  

Two pemphigoid cases with mucous membrane involvement successfully treated with baricitinib

JEADV Clinical Practice
Both bullous pemphigoid and mucous membrane pemphigoid are autoimmune bullous diseases that can be challenging to treat in individual cases. Janus kinase inhibitors have shown efficacy in several autoimmune and inflammatory diseases, although these drugs
Tamás Malkovics, Orsolya N. Horváth, Miklós Sárdy   +2 more
doaj   +1 more source

Association of Comorbid Trauma and Stressor‐Related Disorders in Pemphigus and Pemphigoid: A Case‐Control Study

The Journal of Dermatology, Volume 53, Issue 6, Page 961-962, June 2026.
Isabella J. Tan, Gaurav N. Pathak, Suraj S. Pathak, Babar K. Rao, Mohammad Jafferany   +4 more
wiley   +1 more source